TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 33382407

Group type: EXPERIMENTAL
Intervention: SQLNS (small‐quantity lipid‐based nutrient supplementation)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control (no SQLNS)
Number of subjects: 48
Study: 32741829

Group type: EXPERIMENTAL
Intervention: Music Playlist Guide
Number of subjects: 45

Group type: COMPARATOR
Intervention: Waitlist Control Group
Number of subjects: 45
Study: 35895987

Group type: EXPERIMENTAL
Intervention: Pulsatile flow (group P)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Nonpulsatile flow (group NP)
Number of subjects: 12
Study: 32875388

Group type: EXPERIMENTAL
Intervention: Polymyxin B (PB) 50 IU, q12h
Number of subjects: 42
Study: 33478205

Group type: EXPERIMENTAL
Intervention: Mediterranean diet
Number of subjects: 160

Group type: COMPARATOR
Intervention: Low-fat diet
Number of subjects: 160
Study: 34022697

Group type: EXPERIMENTAL
Intervention: TPC-ICT (docetaxel, cisplatin, cetuximab)
Number of subjects: 100

Group type: COMPARATOR
Intervention: TPF-ICT (docetaxel, cisplatin, 5-FU)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: TPC-ICT
Number of subjects: 100

Group type: COMPARATOR
Intervention: TPF-ICT
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Both TPC and TPF arms
Number of subjects: 100
Study: 32373917

Group type: EXPERIMENTAL
Intervention: Arabic decision aid with usual care
Number of subjects: 92

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 92
Study: 36272926

Group type: EXPERIMENTAL
Intervention: Exercise therapy combined with nutritional supplementation (Ex + Nutr; n = 29)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Exercise therapy alone (Ex; n = 29)
Number of subjects: 58
Study: 33899934

Group type: EXPERIMENTAL
Intervention: Various dosing regimen optimization strategies for ADCs including body weight cap dosing, treatment duration capping, dose schedule adjustments, response-guided dosing recommendations, and randomized dose-finding.
Number of subjects: 0
Study: 34558152

Group type: EXPERIMENTAL
Intervention: Self-care training program using smartphones (21 sessions, virtual)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 54
Study: 32488891

Group type: EXPERIMENTAL
Intervention: Botulinum toxin-A (BTX-A) injection and a home-based exercise program
Number of subjects: 33

Group type: COMPARATOR
Intervention: Home-based exercise program
Number of subjects: 33
Study: 36002073

Group type: EXPERIMENTAL
Intervention: Personalized educational session with a reminder bottle
Number of subjects: 200

Group type: COMPARATOR
Intervention: Control session on general eye health
Number of subjects: 200
Study: 34167656

Group type: EXPERIMENTAL
Intervention: Active tDCS (5 daily sessions, 1mA for 20min over parieto-occipital regions)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 27
Study: 32412417

Group type: EXPERIMENTAL
Intervention: Smarter Pregnancy program (intervention group)
Number of subjects: 218

Group type: COMPARATOR
Intervention: Control group (no coaching)
Number of subjects: 218
Study: 34612012

Group type: EXPERIMENTAL
Intervention: Personalized exercise and nutrition based programme (experimental arm)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Standard care (control arm)
Number of subjects: 45
Study: 32144418

Group type: EXPERIMENTAL
Intervention: Cognitive Adaptation Training (CAT)
Number of subjects: 89

Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 89
Study: 34508600

Group type: EXPERIMENTAL
Intervention: Lactulose (20 g)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Water intake (control)
Number of subjects: 10
Study: 33933751

Group type: EXPERIMENTAL
Intervention: Intravenous fish oil (IV-FO)
Number of subjects: 477

Group type: COMPARATOR
Intervention: Control group (CNTR)
Number of subjects: 477
Study: 34321377

Group type: EXPERIMENTAL
Intervention: LVA ablation (group B)
Number of subjects: 402

Group type: EXPERIMENTAL
Intervention: LVA without ablation (group C)
Number of subjects: 402

Group type: COMPARATOR
Intervention: No LVA (group A)
Number of subjects: 402

Group type: COMPARATOR
Intervention: Incomplete voltage map (group D)
Number of subjects: 402

Group type: EXPERIMENTAL
Intervention: Patients with LVAs (group B+C)
Number of subjects: 402

Group type: COMPARATOR
Intervention: Patients without LVAs (group A)
Number of subjects: 402
Study: 32772873

Group type: EXPERIMENTAL
Intervention: Intranasal ketamine (50 mg)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Fentanyl alone (control)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Follow-up study
Number of subjects: 100
Study: 34701230

Group type: EXPERIMENTAL
Intervention: SABR (Stereotactic Ablative Radiotherapy)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: SABR
Number of subjects: 0
Study: 32585077

Group type: EXPERIMENTAL
Intervention: Differentiated service delivery (DSD) model implementation including repeat prescription collection strategies (RPCS)
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Enhanced counselling and tracing patients lost-to-follow-up for patients not stable on treatment
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Counselling for new HIV patients
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Training for providers on DSD model
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Access to data for providers
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Overall implementation of DSD models
Number of subjects: 88
Study: 34738278

Group type: EXPERIMENTAL
Intervention: Topical anesthesia + LLLT (diode laser: 810 nm; continuous mode; 0.3W; 20 s; 69 J/cm2)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Topical anesthesia + LLLT
Number of subjects: 60

Group type: COMPARATOR
Intervention: Topical anesthesia
Number of subjects: 60
Study: 33373935

Group type: COMPARATOR
Intervention: Control diet meeting NRC (2007) requirements (CON)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Diet with 10% higher ME using corn grain (HEC)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Diet with 10% higher ME using flaxseed (HEF)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Diet with 10% higher MP using rumen-protected lysine and methionine (PRO)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control diet (CON)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Moderately over-fed ewes with MP and ME
Number of subjects: 32
Study: 33076294

Group type: EXPERIMENTAL
Intervention: Low plasma total cysteine (tCys) (≤25th percentile)
Number of subjects: 2102

Group type: COMPARATOR
Intervention: Plasma total cysteine (tCys) >25th percentile
Number of subjects: 2102
Study: 35124321

Group type: EXPERIMENTAL
Intervention: Rivaroxaban
Number of subjects: 7213

Group type: COMPARATOR
Intervention: Aspirin
Number of subjects: 7213
Study: 33481085

Group type: EXPERIMENTAL
Intervention: Optical frequency domain imaging (OFDI)
Number of subjects: 20
Study: 32840930

Group type: EXPERIMENTAL
Intervention: Sacubitril–valsartan
Number of subjects: 4795

Group type: COMPARATOR
Intervention: Valsartan
Number of subjects: 4795

Group type: EXPERIMENTAL
Intervention: Hyperuricaemia
Number of subjects: 4795
Study: 35043553

Group type: EXPERIMENTAL
Intervention: Porcine acellular dermal matrix (pADM)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Autogenous connective tissue graft (CTG)
Number of subjects: 20
Study: 36495162

Group type: EXPERIMENTAL
Intervention: Dexcom G4 CGM sensor
Number of subjects: 172

Group type: EXPERIMENTAL
Intervention: Abbott Libre Pro CGM sensor
Number of subjects: 172
Study: 34432983

Group type: EXPERIMENTAL
Intervention: Mainstream American English recordings
Number of subjects: 73

Group type: COMPARATOR
Intervention: AAE recordings
Number of subjects: 73
Study: 35905275

Group type: EXPERIMENTAL
Intervention: Chlorhexidine digluconate mouth rinse
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Chlorhexidine digluconate lozenges
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Povidone iodine mouth rinse
Number of subjects: 0

Group type: COMPARATOR
Intervention: Saline (control group)
Number of subjects: 0
Study: 33477165

Group type: EXPERIMENTAL
Intervention: Reflexology applied for 20 min (10 min for each foot) twice a day with 8-hour intervals on the first and second days after CS
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group received routine nursing care for approximately 3 hours after CS
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Reflexology intervention
Number of subjects: 60
Study: 32756124

Group type: EXPERIMENTAL
Intervention: Microendoscopic discectomy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Open surgery
Number of subjects: 0
Study: 33829300

Group type: EXPERIMENTAL
Intervention: Open release
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Arthroscopic release
Number of subjects: 80
Study: 32588746

Group type: EXPERIMENTAL
Intervention: Early feeding group (soft food diet served at Postoperative Hour 2)
Number of subjects: 262

Group type: COMPARATOR
Intervention: On-demand feeding group (eating whenever they wanted to upon return to the ward)
Number of subjects: 262

Group type: EXPERIMENTAL
Intervention: Early feeding group
Number of subjects: 262

Group type: COMPARATOR
Intervention: On-demand feeding group
Number of subjects: 262
Study: 32054484

Group type: EXPERIMENTAL
Intervention: Vaccination with evidence (BCG, DPT-Hi+Hb 3, Measles/Rubella) in children aged 12-23 months
Number of subjects: 1430

Group type: EXPERIMENTAL
Intervention: Missed vaccination appointments for BCG and Measles/Rubella
Number of subjects: 1430

Group type: EXPERIMENTAL
Intervention: Dropout rates for vaccinations in children aged 12-23 months
Number of subjects: 1430
Study: 33835715

Group type: COMPARATOR
Intervention: Vancomycin trough concentration (VTC) less than 10 mg/L
Number of subjects: 7220

Group type: EXPERIMENTAL
Intervention: Vancomycin trough concentration (VTC) 10–15 mg/L
Number of subjects: 7220

Group type: EXPERIMENTAL
Intervention: Vancomycin trough concentration (VTC) 15–20 mg/L
Number of subjects: 7220

Group type: EXPERIMENTAL
Intervention: Vancomycin trough concentration (VTC) greater than 20 mg/L
Number of subjects: 7220
Study: 33030868

Group type: EXPERIMENTAL
Intervention: eLearning module on prepubertal bleeding
Number of subjects: 97

Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 97
Study: 97266229

Group type: EXPERIMENTAL
Intervention: Insulin administration during hyperglycaemic conditions
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Insulin administration during normoglycaemic conditions
Number of subjects: 6

Group type: COMPARATOR
Intervention: Insulin administration in normal subjects
Number of subjects: 6
Study: 36332161

Group type: COMPARATOR
Intervention: Bevacizumab for 15 months
Number of subjects: 927

Group type: EXPERIMENTAL
Intervention: Bevacizumab for 30 months
Number of subjects: 927
Study: 34455940

Group type: EXPERIMENTAL
Intervention: Multispecies probiotics
Number of subjects: 584
Study: 35791476

Group type: EXPERIMENTAL
Intervention: Garlic (KWAI) 300 mg daily in doses of 0.3g, 0.6g, 0.9g, 1.2g, and 1.5g for 24 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: COMPARATOR
Intervention: Simvastatin (standard lipid-lowering agent)
Number of subjects: 0
Study: 33895619

Group type: EXPERIMENTAL
Intervention: Intraoperative digital subtraction angiography (ioDSA)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Indocyanine green (ICG) angiography
Number of subjects: 54
Study: 32166877

Group type: EXPERIMENTAL
Intervention: Azithromycin alongside seasonal malaria chemoprevention (sulfadoxine–pyrimethamine plus amodiaquine)
Number of subjects: 19578

Group type: COMPARATOR
Intervention: Placebo alongside seasonal malaria chemoprevention (sulfadoxine–pyrimethamine plus amodiaquine)
Number of subjects: 19578
Study: 35333803

Group type: EXPERIMENTAL
Intervention: Anal bulking agent with polyacrylate‐polyalcohol copolymer particles
Number of subjects: 0

Group type: COMPARATOR
Intervention: Endoanal electrical stimulation with biofeedback
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Quality of life evaluation
Number of subjects: 0
Study: 33452662

Group type: EXPERIMENTAL
Intervention: Resuscitation preference conversations conducted by trained nurses in group I (n = 165)
Number of subjects: 329

Group type: COMPARATOR
Intervention: Resuscitation preference conversations conducted by trained nurses in group II (n = 164)
Number of subjects: 329

Group type: EXPERIMENTAL
Intervention: Patients with discordance
Number of subjects: 329
Study: 32448336

Group type: EXPERIMENTAL
Intervention: Intravenous buprenorphine (0.02 mg/kg)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Intramuscular buprenorphine (0.02 mg/kg)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Subcutaneous buprenorphine (0.02 mg/kg)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Carprofen (4.4 mg/kg SC)
Number of subjects: 24
Study: 34346091

Group type: EXPERIMENTAL
Intervention: Nutritional supplementation (multi-nutrient, protein-rich formula)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 160
Study: 34453013

Group type: COMPARATOR
Intervention: CHO (Carbohydrate drink 1.2 g kg‐1 2 hr‐1)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: CHO + PRO (Carbohydrate drink with whey protein concentrate 0.3 g kg‐1 2 hr‐1)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: CHO + PROH (Carbohydrate drink with whey protein hydrolysate 0.3 g kg‐1 2 hr‐1)
Number of subjects: 12

Group type: COMPARATOR
Intervention: CHO
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: CHO + PRO
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: CHO + PROH
Number of subjects: 12
Study: 36170317

Group type: EXPERIMENTAL
Intervention: Autologous bone
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: PRGF + autologous bone
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control (spontaneous healing)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: PRGF + DFDBA
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: PRGF
Number of subjects: 30
Study: 34656170

Group type: EXPERIMENTAL
Intervention: Exercise + PBM (EAP)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Exercise + Sham PBM (ESP)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 36
Study: 32233173

Group type: EXPERIMENTAL
Intervention: Air purifier filter (filter-on condition)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Matched placebo (filter-off condition)
Number of subjects: 30
Study: 33549072

Group type: EXPERIMENTAL
Intervention: ShootSafe (interactive educational website)
Number of subjects: 162

Group type: COMPARATOR
Intervention: Active control website
Number of subjects: 162
Study: 32620104

Group type: EXPERIMENTAL
Intervention: Melissa officinalis (2 g)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Lavandula angustifolia (2 g)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Fluoxetine (20 mg)
Number of subjects: 45
Study: 36347730

Group type: EXPERIMENTAL
Intervention: Liposomal bupivacaine (LB) plus plain bupivacaine (PB)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Plain bupivacaine (PB)
Number of subjects: 60
Study: 34424165

Group type: EXPERIMENTAL
Intervention: Ring Screening (RS) with niclosamide treatment
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Ring Treatment (RT) with presumptive niclosamide treatment
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Mass Treatment (MT) with niclosamide treatment every 6 months
Number of subjects: 23
Study: 36178956

Group type: EXPERIMENTAL
Intervention: Combined short-axis out-of-plane and long-axis in-plane approach
Number of subjects: 110

Group type: COMPARATOR
Intervention: Long-axis in-plane approach
Number of subjects: 110
Study: 34836009

Group type: EXPERIMENTAL
Intervention: Increased fruit and vegetable intake (FV)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Control group (CON)
Number of subjects: 66
Study: 32202035

Group type: EXPERIMENTAL
Intervention: Exposed wound (n=165)
Number of subjects: 331

Group type: COMPARATOR
Intervention: Dressed wound (n=166)
Number of subjects: 331
Study: 36107229

Group type: EXPERIMENTAL
Intervention: Intravenous iron (ferric derisomaltose)
Number of subjects: 201

Group type: COMPARATOR
Intervention: Oral iron (ferrous fumarate)
Number of subjects: 201
Study: 33622069

Group type: EXPERIMENTAL
Intervention: Modified bedside post‐pyloric feeding tube placement (M group)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Conventional Corpak protocol (C group)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Standard electromagnetic‐guided tube placement (EM group)
Number of subjects: 63
Study: 32912462

Group type: EXPERIMENTAL
Intervention: UFR-guided hydration (hydration controlled by the RenalGuard System to reach UFR ≥300 ml/h)
Number of subjects: 702

Group type: COMPARATOR
Intervention: LVEDP-guided hydration (normal saline infusion rate adjusted according to LVEDP)
Number of subjects: 702

Group type: EXPERIMENTAL
Intervention: UFR-guided hydration
Number of subjects: 702

Group type: COMPARATOR
Intervention: LVEDP-guided hydration
Number of subjects: 702
Study: 35436920

Group type: EXPERIMENTAL
Intervention: Semi-recumbent vibration exercise
Number of subjects: 32

Group type: COMPARATOR
Intervention: Sham exercise
Number of subjects: 32
Study: 35421821

Group type: EXPERIMENTAL
Intervention: Continuous levobupivacaine/ropivacaine
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 32392833

Group type: EXPERIMENTAL
Intervention: Augmented-reality-based muscle reduction prevention exercise program (30-min program, 5 times a week for 12 weeks)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Augmented-reality-based muscle reduction prevention exercise program
Number of subjects: 27
Study: 35589024

Group type: EXPERIMENTAL
Intervention: Qigong and Tai Chi Easy (QTC)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: QTC plus HRV biofeedback
Number of subjects: 50
Study: 33187696

Group type: EXPERIMENTAL
Intervention: Ethanol stove (n = 113)
Number of subjects: 223

Group type: COMPARATOR
Intervention: Firewood/Kerosene (n = 110)
Number of subjects: 223
Study: 32228328

Group type: EXPERIMENTAL
Intervention: Minimum attenuation set to 130 HU
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Minimum attenuation set to 150 HU
Number of subjects: 40

Group type: COMPARATOR
Intervention: Minimum attenuation change from 130 HU to 150 HU
Number of subjects: 40
Study: 33462482

Group type: EXPERIMENTAL
Intervention: ABO histo-blood groups and FUT2 secretor status
Number of subjects: 8956

Group type: EXPERIMENTAL
Intervention: Gut microbes
Number of subjects: 8956
Study: 33028560

Group type: EXPERIMENTAL
Intervention: Joint visits with adult and paediatric gastroenterologist (4 visits between ages 17 and 18)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Usual care (only meeting with paediatric gastroenterologist)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Joint visits
Number of subjects: 160
Study: 35147535

Group type: EXPERIMENTAL
Intervention: Integrated Care Pathway including a sequential pharmacological algorithm and structured behavioral interventions
Number of subjects: 0

Group type: COMPARATOR
Intervention: Treatment-as-usual
Number of subjects: 0
Study: 33105345

Group type: EXPERIMENTAL
Intervention: Pelvic radiation therapy (RT)
Number of subjects: 180

Group type: COMPARATOR
Intervention: No pelvic radiation therapy (no-RT)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Comparison of mesh complications between RT and no-RT groups
Number of subjects: 180
Study: 32870162

Group type: EXPERIMENTAL
Intervention: Use of MI and CBT components, specifically the listing of high-risk situations.
Number of subjects: 503

Group type: EXPERIMENTAL
Intervention: Percentage of change talk and number of listed strategies to deal with high-risk situations.
Number of subjects: 503
Study: 34148714

Group type: EXPERIMENTAL
Intervention: Pomegranate juice/extract
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study: 32406964

Group type: EXPERIMENTAL
Intervention: Mouthing of visibly dirty fomites
Number of subjects: 494

Group type: EXPERIMENTAL
Intervention: Mouthing of visibly dirty objects
Number of subjects: 494

Group type: EXPERIMENTAL
Intervention: Mouthing of dirt
Number of subjects: 494

Group type: EXPERIMENTAL
Intervention: Mouthing of feces
Number of subjects: 494

Group type: EXPERIMENTAL
Intervention: Observation of mouthing visibly dirty fomites
Number of subjects: 494

Group type: EXPERIMENTAL
Intervention: Observation of mouthing objects
Number of subjects: 494

Group type: EXPERIMENTAL
Intervention: Observation of mouthing soil
Number of subjects: 494

Group type: EXPERIMENTAL
Intervention: Observation of mouthing feces
Number of subjects: 494

Group type: EXPERIMENTAL
Intervention: Mouthing of visibly dirty fomites among children 12-18 months
Number of subjects: 494

Group type: EXPERIMENTAL
Intervention: Mouthing of visibly dirty fomites among children 12-18 months (observed)
Number of subjects: 494

Group type: EXPERIMENTAL
Intervention: Mouthing feces and odds of diarrhea
Number of subjects: 494
Study: 35524339

Group type: EXPERIMENTAL
Intervention: AZD1981
Number of subjects: 81

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 81
Study: 32818949

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC) intravenous infusion
Number of subjects: 67

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 67
Study: 35545106

Group type: EXPERIMENTAL
Intervention: PI-RADS v2.1
Number of subjects: 239

Group type: EXPERIMENTAL
Intervention: Combined PI-RADS v2.1 scores 1 and 2
Number of subjects: 239
Study: 32660261

Group type: EXPERIMENTAL
Intervention: Scapular exercise with cognitive functional therapy
Number of subjects: 72

Group type: COMPARATOR
Intervention: Scapular exercise alone
Number of subjects: 72
Study: 36274193

Group type: EXPERIMENTAL
Intervention: Boolean2.0 criteria
Number of subjects: 2048

Group type: COMPARATOR
Intervention: Boolean1.0 criteria
Number of subjects: 2048

Group type: EXPERIMENTAL
Intervention: SDAI remission criteria
Number of subjects: 2048

Group type: EXPERIMENTAL
Intervention: CDAI remission criteria
Number of subjects: 2048
Study: 33729393

Group type: EXPERIMENTAL
Intervention: Footwear designed to enhance energy return (TPU)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Minimalist shoes
Number of subjects: 11
Study: 35861974

Group type: EXPERIMENTAL
Intervention: Intravitreal rt‐PA injection before vitrectomy
Number of subjects: 38

Group type: COMPARATOR
Intervention: No injection (control group)
Number of subjects: 38
Study: 36127726

Group type: EXPERIMENTAL
Intervention: Fluticasone furoate/vilanterol (FF/VI) 100 µg/25 µg once daily for 14 days
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27